MeSH Browser

MeSH Heading: Fadrozole
Tree Number(s): D02.626.400; D03.383.129.308.270
Unique ID: D017316
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D017316
Scope Note: A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer.
Entry Term(s): CGS 020286A; CGS-020286A; CGS-16949A; CGS020286A; FAD 286; FAD-286; FAD286; Fadrozole Hydrochloride; Fadrozole Monohydrochloride
Pharm Action: Estrogen Antagonists
Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Registry Number: H3988M64PU
Related Numbers: 102676-31-3; 102676-47-1; H0Q44H4ECQ
CAS Type 1 Name: Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-
Previous Indexing: Imidazoles (1988-1992); Nitriles (1988-1992)
Public MeSH Note: 1993; CGS 16949A was indexed under IMIDAZOLES & NITRILES 1988-1992; CGS 020286A was indexed under FADROZOLE 2012, and under IMIDAZOLES & IMIDAZOLES 2010-2011
History Note: 1993
Date Established: 1993/01/01
Date of Entry: 1992/05/19
Revision Date: 2016/07/01

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Fadrozole MeSH Descriptor Data 2024